Algernon Pharmaceuticals Inc. (CSE: AGN)

Algernon Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	2	3	3	13	17	45
Market Cap Growth	84.25%	10.13%	-79.52%	-24.12%	-62.61%	627.75%
Enterprise Value	1	2	2	12	13	36
Last Close Price	0.08	0.10	0.17	1.13	2.09	6.91
PB Ratio	1.22	1.32	1.77	2.26	1.84	3.67
P/TBV Ratio	-	-	-	34.49	4.25	6.23
Quick Ratio	0.20	0.34	0.08	0.82	4.60	12.11
Current Ratio	0.23	0.42	0.12	1.12	4.80	12.75
Return on Equity (ROE)	-25.89%	-27.62%	-191.06%	-82.15%	-72.51%	-99.34%
Return on Assets (ROA)	-35.42%	-35.41%	-50.99%	-39.28%	-42.89%	-58.17%
Return on Capital (ROIC)	-96.19%	-79.11%	-88.61%	-48.70%	-46.16%	-61.46%
Earnings Yield	-21.27%	-17.55%	-260.51%	-47.64%	-46.18%	-19.06%
FCF Yield	-133.09%	-94.52%	-98.08%	-22.92%	-46.71%	-14.76%
Buyback Yield / Dilution	-37.20%	-32.35%	-117.87%	-11.59%	-76.84%	-97.19%
Total Shareholder Return	-37.20%	-32.35%	-117.87%	-11.59%	-76.84%	-97.19%

Source: S&P Capital IQ. Standard template. Financial Sources.